Open AccessA biologically effective dose threshold for stereotactic body radiation therapy—can we put the issue to BED?
Author(s) -
M. Mix,
Jeffrey A. Bogart
Publication year - 2020
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm-20-3689
Subject(s) - medicine , medical physics
Department of Radiation Oncology, Upstate Cancer Center, SUNY Upstate Medical University, Syracuse, NY, USA Correspondence to: Michael Mix, MD. Assistant Professor, Department of Radiation Oncology, Upstate Cancer Center, SUNY Upstate Medical University, 750 East Adams St, Syracuse, NY 13210, USA. Email: mixm@upstate.edu. Comment on: Moreno AC, Fellman B, Hobbs BP, et al. Biologically Effective Dose in Stereotactic Body Radiotherapy and Survival for Patients With Early-Stage NSCLC. J Thorac Oncol 2020;15:101-9.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom